HENRY SCHEIN INC (HSIC) Stock Fundamental Analysis
USA - NASDAQ:HSIC - US8064071025 - Common Stock
65.65 USD
-1.38 (-2.06%)
Overall HSIC gets a fundamental rating of 4 out of 10. We evaluated HSIC against 101 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of HSIC while its profitability can be described as average. HSIC has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year HSIC was profitable.
HSIC had a positive operating cash flow in the past year.
In the past 5 years HSIC has always been profitable.
In the past 5 years HSIC always reported a positive cash flow from operatings.
1.2 Ratios
HSIC has a Return On Assets of 3.57%. This is in the better half of the industry: HSIC outperforms 68.32% of its industry peers.
The Return On Equity of HSIC (11.29%) is better than 75.25% of its industry peers.
The Return On Invested Capital of HSIC (6.75%) is better than 68.32% of its industry peers.
The Average Return On Invested Capital over the past 3 years for HSIC is in line with the industry average of 9.20%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.57% | ||
| ROE | 11.29% | ||
| ROIC | 6.75% |
ROA(3y)4.67%
ROA(5y)5.33%
ROE(3y)12.83%
ROE(5y)13.8%
ROIC(3y)8.02%
ROIC(5y)8.48%
1.3 Margins
With a decent Profit Margin value of 3.05%, HSIC is doing good in the industry, outperforming 65.35% of the companies in the same industry.
In the last couple of years the Profit Margin of HSIC has declined.
The Operating Margin of HSIC (6.08%) is better than 62.38% of its industry peers.
HSIC's Operating Margin has declined in the last couple of years.
HSIC's Gross Margin of 31.33% is in line compared to the rest of the industry. HSIC outperforms 57.43% of its industry peers.
HSIC's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.08% | ||
| PM (TTM) | 3.05% | ||
| GM | 31.33% |
OM growth 3Y-5.7%
OM growth 5Y-4.55%
PM growth 3Y-15.43%
PM growth 5Y-15.06%
GM growth 3Y2.29%
GM growth 5Y0.47%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so HSIC is destroying value.
Compared to 1 year ago, HSIC has less shares outstanding
Compared to 5 years ago, HSIC has less shares outstanding
Compared to 1 year ago, HSIC has a worse debt to assets ratio.
2.2 Solvency
HSIC has an Altman-Z score of 2.64. This is not the best score and indicates that HSIC is in the grey zone with still only limited risk for bankruptcy at the moment.
HSIC has a Altman-Z score (2.64) which is in line with its industry peers.
The Debt to FCF ratio of HSIC is 9.04, which is on the high side as it means it would take HSIC, 9.04 years of fcf income to pay off all of its debts.
HSIC has a Debt to FCF ratio (9.04) which is comparable to the rest of the industry.
HSIC has a Debt/Equity ratio of 0.87. This is a neutral value indicating HSIC is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.87, HSIC is in line with its industry, outperforming 40.59% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.87 | ||
| Debt/FCF | 9.04 | ||
| Altman-Z | 2.64 |
ROIC/WACC0.77
WACC8.78%
2.3 Liquidity
HSIC has a Current Ratio of 1.41. This is a normal value and indicates that HSIC is financially healthy and should not expect problems in meeting its short term obligations.
HSIC has a Current ratio (1.41) which is in line with its industry peers.
HSIC has a Quick Ratio of 1.41. This is a bad value and indicates that HSIC is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of HSIC (0.78) is worse than 79.21% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.41 | ||
| Quick Ratio | 0.78 |
3. Growth
3.1 Past
HSIC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.12%, which is quite good.
Measured over the past 5 years, HSIC shows a small growth in Earnings Per Share. The EPS has been growing by 6.19% on average per year.
HSIC shows a small growth in Revenue. In the last year, the Revenue has grown by 2.29%.
HSIC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.88% yearly.
EPS 1Y (TTM)8.12%
EPS 3Y1.6%
EPS 5Y6.19%
EPS Q2Q%-10.57%
Revenue 1Y (TTM)2.29%
Revenue growth 3Y0.73%
Revenue growth 5Y4.88%
Sales Q2Q%3.32%
3.2 Future
HSIC is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.78% yearly.
Based on estimates for the next years, HSIC will show a small growth in Revenue. The Revenue will grow by 3.67% on average per year.
EPS Next Y3.78%
EPS Next 2Y5.95%
EPS Next 3Y6.77%
EPS Next 5Y7.78%
Revenue Next Year1.76%
Revenue Next 2Y2.65%
Revenue Next 3Y3.02%
Revenue Next 5Y3.67%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 14.09, the valuation of HSIC can be described as correct.
81.19% of the companies in the same industry are more expensive than HSIC, based on the Price/Earnings ratio.
HSIC's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.86.
HSIC is valuated correctly with a Price/Forward Earnings ratio of 12.34.
HSIC's Price/Forward Earnings ratio is rather cheap when compared to the industry. HSIC is cheaper than 83.17% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.32, HSIC is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.09 | ||
| Fwd PE | 12.34 |
4.2 Price Multiples
77.23% of the companies in the same industry are more expensive than HSIC, based on the Enterprise Value to EBITDA ratio.
The rest of the industry has a similar Price/Free Cash Flow ratio as HSIC.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 23.84 | ||
| EV/EBITDA | 9.39 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HSIC does not grow enough to justify the current Price/Earnings ratio.
HSIC has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)3.73
PEG (5Y)2.27
EPS Next 2Y5.95%
EPS Next 3Y6.77%
5. Dividend
5.1 Amount
No dividends for HSIC!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:HSIC (10/6/2025, 1:26:06 PM)
65.65
-1.38 (-2.06%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners99.98%
Inst Owner Change0%
Ins Owners0.77%
Ins Owner Change-0.21%
Market Cap7.96B
Analysts71.3
Price Target74.93 (14.14%)
Short Float %9.01%
Short Ratio5.23
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.98%
Min EPS beat(2)-9.54%
Max EPS beat(2)1.57%
EPS beat(4)2
Avg EPS beat(4)-2.19%
Min EPS beat(4)-9.54%
Max EPS beat(4)2.52%
EPS beat(8)3
Avg EPS beat(8)-1.5%
EPS beat(12)4
Avg EPS beat(12)-1.91%
EPS beat(16)7
Avg EPS beat(16)0.73%
Revenue beat(2)0
Avg Revenue beat(2)-2.6%
Min Revenue beat(2)-3.77%
Max Revenue beat(2)-1.43%
Revenue beat(4)0
Avg Revenue beat(4)-3.52%
Min Revenue beat(4)-5.06%
Max Revenue beat(4)-1.43%
Revenue beat(8)0
Avg Revenue beat(8)-3.65%
Revenue beat(12)0
Avg Revenue beat(12)-3.48%
Revenue beat(16)2
Avg Revenue beat(16)-2.33%
PT rev (1m)1.38%
PT rev (3m)-3.44%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.13%
EPS NY rev (1m)-0.04%
EPS NY rev (3m)-1.09%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.42%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)0.33%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.09 | ||
| Fwd PE | 12.34 | ||
| P/S | 0.62 | ||
| P/FCF | 23.84 | ||
| P/OCF | 15.55 | ||
| P/B | 2.31 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.39 |
EPS(TTM)4.66
EY7.1%
EPS(NY)5.32
Fwd EY8.11%
FCF(TTM)2.75
FCFY4.2%
OCF(TTM)4.22
OCFY6.43%
SpS105.33
BVpS28.41
TBVpS-13.86
PEG (NY)3.73
PEG (5Y)2.27
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.57% | ||
| ROE | 11.29% | ||
| ROCE | 9.84% | ||
| ROIC | 6.75% | ||
| ROICexc | 6.86% | ||
| ROICexgc | 16.83% | ||
| OM | 6.08% | ||
| PM (TTM) | 3.05% | ||
| GM | 31.33% | ||
| FCFM | 2.61% |
ROA(3y)4.67%
ROA(5y)5.33%
ROE(3y)12.83%
ROE(5y)13.8%
ROIC(3y)8.02%
ROIC(5y)8.48%
ROICexc(3y)8.17%
ROICexc(5y)8.74%
ROICexgc(3y)19.66%
ROICexgc(5y)20.9%
ROCE(3y)10.93%
ROCE(5y)11.41%
ROICexcg growth 3Y-9.94%
ROICexcg growth 5Y-7.93%
ROICexc growth 3Y-12.98%
ROICexc growth 5Y-8.63%
OM growth 3Y-5.7%
OM growth 5Y-4.55%
PM growth 3Y-15.43%
PM growth 5Y-15.06%
GM growth 3Y2.29%
GM growth 5Y0.47%
F-Score5
Asset Turnover1.17
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.87 | ||
| Debt/FCF | 9.04 | ||
| Debt/EBITDA | 2.78 | ||
| Cap/Depr | 59.53% | ||
| Cap/Sales | 1.39% | ||
| Interest Coverage | 5.4 | ||
| Cash Conversion | 47.58% | ||
| Profit Quality | 85.86% | ||
| Current Ratio | 1.41 | ||
| Quick Ratio | 0.78 | ||
| Altman-Z | 2.64 |
F-Score5
WACC8.78%
ROIC/WACC0.77
Cap/Depr(3y)61.22%
Cap/Depr(5y)49.53%
Cap/Sales(3y)1.25%
Cap/Sales(5y)0.97%
Profit Quality(3y)112.93%
Profit Quality(5y)114.98%
High Growth Momentum
Growth
EPS 1Y (TTM)8.12%
EPS 3Y1.6%
EPS 5Y6.19%
EPS Q2Q%-10.57%
EPS Next Y3.78%
EPS Next 2Y5.95%
EPS Next 3Y6.77%
EPS Next 5Y7.78%
Revenue 1Y (TTM)2.29%
Revenue growth 3Y0.73%
Revenue growth 5Y4.88%
Sales Q2Q%3.32%
Revenue Next Year1.76%
Revenue Next 2Y2.65%
Revenue Next 3Y3.02%
Revenue Next 5Y3.67%
EBIT growth 1Y25.93%
EBIT growth 3Y-5.01%
EBIT growth 5Y0.11%
EBIT Next Year14.87%
EBIT Next 3Y8.36%
EBIT Next 5YN/A
FCF growth 1Y-37.22%
FCF growth 3Y1.58%
FCF growth 5Y1.99%
OCF growth 1Y-21.59%
OCF growth 3Y6.12%
OCF growth 5Y4.66%